[Inflammatory breast carcinoma and prognosticators of efficacy of primary chemotherapy].

Semiglazov, V F; Zernov, K Iu; Bozhok, A A; Petrovskii, S G; Ivanova, O A; Orlov, A A; Barash, N Iu; Paltuev, R M; Donskikh, R V; Damenia, A O; Kletsel', A E; Kochetova, I A; Efimenko, A V

Semiglazov, V F; Zernov, K Iu; Bozhok, A A; Petrovskii, S G; Ivanova, O A; Orlov, A A; Barash, N Iu; Paltuev, R M; Donskikh, R V; Damenia, A O; Kletsel', A E; Kochetova, I A; Efimenko, A V.

Vopr Onkol ; 53(1): 21-5, 2007.

Article en Ru | MEDLINE | ID: mdl-17649729

RESUMEN

The efficacy of primary chemotherapy for inflammatory breast carcinoma (IBC) was studied vis-a-vis certain symptoms characterizing patient's status and biological features of tumor. It was shown that such factors as estrogen (ER) and progesterone (PR) receptor status and malignancy grade of tumor can be used to predict the efficacy. Negative ER/PR status plus high malignancy grade involved higher frequency of complete pathomorphological responses. Worst prognosis was in patients under 35 years of age, with ductal BC and negative ER/PR status of tumor.

Asunto(s)

Neoplasias de la Mama/tratamiento farmacológico; Neoplasias de la Mama/patología; Carcinoma/tratamiento farmacológico; Carcinoma/patología; Adulto; Biomarcadores de Tumor/análisis; Neoplasias de la Mama/mortalidad; Humanos; Inflamación/tratamiento farmacológico; Inflamación/patología; Pronóstico; Receptores de Estrógenos/análisis; Receptores de Progesterona/análisis; Análisis de Supervivencia; Resultado del Tratamiento

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: Ru Revista: Vopr Onkol Año: 2007 Tipo del documento: Article Pais de publicación: Rusia

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links